skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:064313/0859   Pages: 9
Recorded: 07/19/2023
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 15
1
Patent #:
NONE
Issue Dt:
Application #:
18311445
Filing Dt:
05/03/2023
Publication #:
Pub Dt:
11/09/2023
Title:
CYTOKINE BASED ASSESSMENT OF RECIPIENT ABILITY TO RESPOND TO STEM CELL THERAPY FOR CARTILAGE REGENERATION
2
Patent #:
NONE
Issue Dt:
Application #:
18311457
Filing Dt:
05/03/2023
Publication #:
Pub Dt:
11/16/2023
Title:
IMMUNOLOGICAL ENHANCEMENT OF STEM CELL ACTIVITY IN TREATMENT OF OVARIAN FAILURE
3
Patent #:
NONE
Issue Dt:
Application #:
18311464
Filing Dt:
05/03/2023
Publication #:
Pub Dt:
11/16/2023
Title:
PROTECTION FROM OVARIAN FAILURE BY LOW DOSE INTERLEUKIN-2 ADMINISTRATION
4
Patent #:
NONE
Issue Dt:
Application #:
18311474
Filing Dt:
05/03/2023
Publication #:
Pub Dt:
11/16/2023
Title:
STIMULATION OF OVARIAN FUNCTION SUBSEQUENT TO CHEMOTHERAPY AND/OR RADIATION THERAPY USING NATURAL KILLER CELLS
5
Patent #:
NONE
Issue Dt:
Application #:
18311625
Filing Dt:
05/03/2023
Publication #:
Pub Dt:
11/23/2023
Title:
CYTOKINE PRIMED REGENERATIVE CELLS FOR TREATMENT OF OVARIAN FAILURE
6
Patent #:
NONE
Issue Dt:
Application #:
18311768
Filing Dt:
05/03/2023
Publication #:
Pub Dt:
11/23/2023
Title:
DEGENERATING OVARIAN MICROENVIRONMENT RESISTANT MESENCHYMAL STEM CELLS
7
Patent #:
NONE
Issue Dt:
Application #:
18315364
Filing Dt:
05/10/2023
Publication #:
Pub Dt:
11/16/2023
Title:
EXOSOME BASED ASSAYS FOR DETERMINING CANDIDATES FOR OSTEOARTHRITIS STEM CELL THERAPY
8
Patent #:
NONE
Issue Dt:
Application #:
18318465
Filing Dt:
05/16/2023
Publication #:
Pub Dt:
01/04/2024
Title:
REPAIR OF OVARIAN DAMAGE AND DAMPENING OF INFLAMMATORY MICROENVIRONMENT BY ADMINISTRATION OF MONOCYTIC-GRANULOCYTIC PROGENITORS WITH IMMUNE MODULATORY ACTIVITIES
9
Patent #:
NONE
Issue Dt:
Application #:
18329404
Filing Dt:
06/05/2023
Publication #:
Pub Dt:
12/07/2023
Title:
GENE THERAPEUTICS FOR ENHANCEMENT/RESTORATION OF ENDOMETRIAL FUNCTION
10
Patent #:
NONE
Issue Dt:
Application #:
18331029
Filing Dt:
06/07/2023
Publication #:
Pub Dt:
12/07/2023
Title:
CELLULAR REGENERATIVE THERAPEUTICS FOR ENHANCEMENT/RESTORATION OF ENDOMETRIAL FUNCTION
11
Patent #:
NONE
Issue Dt:
Application #:
18331042
Filing Dt:
06/07/2023
Publication #:
Pub Dt:
12/14/2023
Title:
GENERATION OF CONDITIONED MEDIA FROM INDUCIBLE PLURIPOTENT STEM CELL DERIVED MESENCHYMAL STEM CELLS
12
Patent #:
NONE
Issue Dt:
Application #:
18331048
Filing Dt:
06/07/2023
Publication #:
Pub Dt:
12/14/2023
Title:
GENERATION OF CONDITIONED MEDIA FROM INDUCIBLE PLURIPOTENT STEM CELL DERIVED ENDOTHELIAL PROGENITOR CELLS
13
Patent #:
NONE
Issue Dt:
Application #:
18331098
Filing Dt:
06/07/2023
Publication #:
Pub Dt:
12/21/2023
Title:
INDUCIBLE PLURIPOTENT STEM CELL DERIVED REGENERATIVE T CELLS
14
Patent #:
NONE
Issue Dt:
Application #:
18348288
Filing Dt:
07/06/2023
Publication #:
Pub Dt:
01/18/2024
Title:
OVERCOMING TNF-ALPHA BLOCKADE RESISTANCE IN RHEUMATOID ARTHRITIS BY REGENERATIVE T REGULATORY CELL THERAPY
15
Patent #:
NONE
Issue Dt:
Application #:
18348292
Filing Dt:
07/06/2023
Publication #:
Pub Dt:
01/25/2024
Title:
TREATMENT OF LIMB ISCHEMIA BY BONE MARROW STEM CELLS AND MODIFICATION OF DISEASED MICROENVIRONMENT
Assignors
1
Exec Dt:
07/12/2023
2
Exec Dt:
07/17/2023
3
Exec Dt:
07/17/2023
Assignee
1
3008 W. LUPINE AVE.
PHOENIX, ARIZONA 85029
Correspondence name and address
MARC BAUMGARTNER
2900 NW CLEARWATER DR.
SUITE 200
BEND, OR 97703

Search Results as of: 05/23/2024 02:34 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT